The Baker Heart and Diabetes Research Institute, Melbourne, Australia; The Alfred Hospital, Melbourne, Australia; University of Melbourne, Melbourne, Australia; Cabrini Hospital, Melbourne, Australia.
Cabrini Hospital, Melbourne, Australia.
JACC Clin Electrophysiol. 2023 Nov;9(11):2291-2299. doi: 10.1016/j.jacep.2023.08.002. Epub 2023 Sep 13.
Pulmonary vein isolation (PVI) is less effective in patients with persistent atrial fibrillation (PsAF). Adjunctive ablation targeting low voltage areas (LVAs) may improve arrhythmia outcomes.
This study aims to compare the outcomes of adding posterior wall isolation (PWI) to PVI, vs PVI alone in PsAF patients with posterior wall LVAs.
The CAPLA (Effect of Catheter Ablation Using Pulmonary Vein Isolation With vs Without Posterior Left Atrial Wall Isolation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation) study was a multicenter, randomized trial involving PsAF patients randomized 1:1 to either PVI alone or PVI with PWI. Voltage mapping performed during pacing pre-ablation was reviewed offline, with LVA defined as bipolar voltage of <0.5 mV. The primary endpoint was freedom from any documented atrial arrhythmia of >30 seconds off antiarrhythmic medication at 12 months after a single ablation procedure in patients with posterior LVA.
A total of 210 patients (average 64.6 ± 9.2 years,73.3% males, median atrial fibrillation duration 4.5 months [IQR: 2 to 8 months]) underwent multipolar left atrial mapping during coronary sinus pacing with posterior LVA present in 69 (32.9%). Patients with posterior LVA were more likely to have LVA in other atrial regions (91.7% vs 57.1%; P < 0.01), larger left atrial diameter (4.8 cm vs 4.4 cm; P < 0.01), and significantly increased risk of atrial arrhythmia recurrence at 12 months (LVA: 56.5% vs no LVA: 41.4%; HR: 1.51; 95% CI: 1.01-2.27; P = 0.04) compared to no posterior LVA. However, the addition of PWI to PVI did not significantly improve freedom from atrial arrhythmia recurrence over PVI alone (PVI with PWI: 44.8% vs PVI: 41.9%; HR: 0.95; 95% CI: 0.51-1.79; P = 0.95).
In patients with PsAF undergoing catheter ablation, posterior LVA was associated with a significant increase in atrial arrhythmia recurrence. However, the addition of PWI in those with posterior LVA did not reduce atrial arrhythmia recurrence over PVI alone.
肺静脉隔离(PVI)在持续性心房颤动(PsAF)患者中的效果较差。针对低电压区(LVAs)的辅助消融可能改善心律失常的结果。
本研究旨在比较在存在后壁 LVA 的 PsAF 患者中,后壁隔离(PWI)联合 PVI 与单纯 PVI 的治疗效果。
CAPLA(使用肺静脉隔离联合与不联合左心房后壁隔离对持续性心房颤动患者消融后心房颤动复发的影响)研究是一项多中心、随机试验,纳入了 210 例 PsAF 患者,随机分为 1:1 组接受单纯 PVI 或 PVI 联合 PWI。在消融前的起搏过程中进行了多极左心房标测,LVAs 定义为双极电压<0.5mV。主要终点是在单次消融后 12 个月时,无抗心律失常药物的任何 30 秒以上记录的心房心律失常。
共纳入 210 例患者(平均年龄 64.6±9.2 岁,73.3%为男性,中位心房颤动持续时间 4.5 个月[IQR:2 至 8 个月]),在冠状窦起搏时行多极左心房标测,后壁 LVA 阳性 69 例(32.9%)。后壁 LVA 患者更有可能存在其他心房区域的 LVA(91.7% vs 57.1%;P<0.01)、更大的左心房直径(4.8cm vs 4.4cm;P<0.01),并且在 12 个月时心房心律失常的复发风险显著增加(后壁 LVA:56.5% vs 无后壁 LVA:41.4%;HR:1.51;95%CI:1.01-2.27;P=0.04)。然而,与单纯 PVI 相比,PVI 联合 PWI 并不能显著提高无心房心律失常复发的概率(PVI 联合 PWI:44.8% vs PVI:41.9%;HR:0.95;95%CI:0.51-1.79;P=0.95)。
在接受导管消融的 PsAF 患者中,后壁 LVA 与心房心律失常复发的显著增加相关。然而,在存在后壁 LVA 的患者中,PWI 的加入并没有降低单纯 PVI 治疗的心房心律失常复发率。